logo

For the Inventor, By the Inventor

Gagny, France

Francis Brion

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Roussel Uclaf, Hoechst Marion Roussel, Other. Active years: 1989-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Brion. Retrieved from https://idiyas.com/inventor/francis-brion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 36(Granted Patents)


Location History:

  • Gagny, FR (1989 - 2001)
  • Balma, FR (2000 - 2001)

Company Filing History:

goldMedal15 out of 854 
 
Roussel Uclaf
 patents
silverMedal4 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 1989-2001

Loading Chart...
Areas of Expertise:
Tricyclic Compounds
Alkyloxy Furanone Derivatives
Hydrocortisone
Steroid Preparation
4-Phenyl-1,2,3,6-Tetrahydropyridines
Pregnatrienes
Intermediate Steroid Compounds
Perhydroindole-2-Carboxylic Acid
20 patents (USPTO):Explore Patents
1. 6268520 - Tricyclic compounds (2001-07-31),
2. 6235899 - Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds (2001-05-22),
3. 6136981 - Preparation of 4-phenyl-1,2,3,6-tetrahydropyridines (2000-10-24),
4. 5959146 - Tricyclic compounds (1999-09-28),
5. 5760256 - Process for the production of 21-acyloxy-4,9 (1998-06-02),
6. 5756722 - Intermediates for the preparation of .DELTA..sup.4,9(11),17(20) (1998-05-26),
7. 5705704 - Tricyclic compounds (1998-01-06),
8. 5594127 - Intermediates for the preparation of .DELTA..sup.4,9(11),17(20) (1997-01-14),
9. 5585482 - Preparation of 11-keto steroids (1996-12-17),
10. 5556962 - Process for the preparation of hydrocortisone (1996-09-17),
11. 5502223 - Process for preparation of .DELTA..sup.4,9(11),16 (1996-03-26),
12. 5502182 - Process for the preparation of hydrocortisone (1996-03-26),
13. 5401864 - Process for preparing 21 acyloxy-.DELTA.4,9(11),16 pregnatrienes (1995-03-28),
14. 5401840 - Intermediate steroid compounds (1995-03-28),
15. 5312964 - Process and intermediates (1994-05-17),

Title: Francis Brion: Innovator in Tricyclic Compounds and Furanone Derivatives

Introduction

Francis Brion, a renowned inventor based in Gagny, France, has made significant contributions to the field of chemistry with a remarkable portfolio of 20 patents. His innovations primarily focus on tricyclic compounds and alkyloxy furanone derivatives, showing a strong commitment to advancing chemical processes and applications.

Latest Patents

Among his latest patents, Francis Brion developed novel tricyclic compounds, as described in his patent that outlines a process for their preparation and their use in creating optically active or racemic derivatives of colchicine and thiocolchicine. Additionally, he has patented a method for preparing alkyloxy furanone derivatives, which includes the compounds obtained through this method and their potential applications.

Career Highlights

Brion's career is marked by his work with notable pharmaceutical companies such as Roussel Uclaf and Hoechst Marion Roussel. His experience in these organizations has enabled him to apply his inventive skills to real-world challenges in drug development and pharmaceutical chemistry.

Collaborations

Throughout his career, Francis Brion has collaborated with esteemed colleagues, including Christian Diolez and Jean Buendia. These collaborations have further enriched his research and innovation endeavors, facilitating the exchange of ideas and expertise in the field.

Conclusion

Francis Brion stands out as a pivotal figure in the realm of chemical innovations. His multiple patents, particularly in tricyclic compounds and furanone derivatives, reflect his dedication to advancing the field. As he continues to develop novel solutions within the chemical industry, his contributions are expected to have a lasting impact on research and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…